- Home
- NERV vs DFLI Comparison
NERV vs DFLI Comparison
Compare NERV & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- DFLI
- Stock Information
- Founded
- NERV 2007
- DFLI 2020
- Country
- NERV United States
- DFLI United States
- Employees
- NERV N/A
- DFLI N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- DFLI Electronic Components
- Sector
- NERV Health Care
- DFLI Technology
- Exchange
- NERV Nasdaq
- DFLI Nasdaq
- Market Cap
- NERV 14.6M
- DFLI 14.5M
- IPO Year
- NERV 2014
- DFLI N/A
- Fundamental
- Price
- NERV $3.73
- DFLI $0.89
- Analyst Decision
- NERV Hold
- DFLI Strong Buy
- Analyst Count
- NERV 1
- DFLI 1
- Target Price
- NERV $4.00
- DFLI $1.50
- AVG Volume (30 Days)
- NERV 8.7M
- DFLI 33.3M
- Earning Date
- NERV 11-05-2025
- DFLI 11-14-2025
- Dividend Yield
- NERV N/A
- DFLI N/A
- EPS Growth
- NERV N/A
- DFLI N/A
- EPS
- NERV N/A
- DFLI N/A
- Revenue
- NERV N/A
- DFLI $54,536,000.00
- Revenue This Year
- NERV N/A
- DFLI $27.77
- Revenue Next Year
- NERV N/A
- DFLI $42.02
- P/E Ratio
- NERV N/A
- DFLI N/A
- Revenue Growth
- NERV N/A
- DFLI 4.80
- 52 Week Low
- NERV $1.15
- DFLI $0.15
- 52 Week High
- NERV $12.46
- DFLI $4.99
- Technical
- Relative Strength Index (RSI)
- NERV 51.45
- DFLI 44.45
- Support Level
- NERV $3.50
- DFLI $1.04
- Resistance Level
- NERV $4.00
- DFLI $1.12
- Average True Range (ATR)
- NERV 0.95
- DFLI 0.16
- MACD
- NERV -0.13
- DFLI -0.06
- Stochastic Oscillator
- NERV 11.92
- DFLI 11.22
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.